Skip to Content

MYLAN TM 180 MYLAN TM 180 (Temozolomide 180 mg)

Pill imprint MYLAN TM 180 MYLAN TM 180 has been identified as Temozolomide 180 mg.

Temozolomide is used in the treatment of glioblastoma multiforme; anaplastic astrocytoma; anaplastic oligodendroglioma; melanoma, metastatic; melanoma and belongs to the drug class alkylating agents. There is positive evidence of human fetal risk during pregnancy. Temozolomide 180 mg is not a controlled substance under the Controlled Substance Act (CSA).

Temozolomide 180 mg MYLAN TM 180 MYLAN TM 180
Discount Card Promo
Temozolomide
Imprint:
MYLAN TM 180 MYLAN TM 180
Strength:
180 mg
Color:
Orange & White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Alkylating agents
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Manufacturer:
Mylan Pharmaceuticals Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide